Gene · 146
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022. | Int J Mol Sci | 2022 | 36012142 | PubTator, text mining | PubMed |
| Wenshenyang recipe treats infertility through hormonal regulation and inflammatory responses revealed by transcriptome analysis and network pharmacology. | Front Pharmacol | 2022 | 36003498 | PubTator, text mining | PubMed |
| A machine learning model for classifying G-protein-coupled receptors as agonists or antagonists. | BMC Bioinformatics | 2022 | 35982407 | PubTator, text mining | PubMed |
| Osteolytic Lesion of the Maxilla in an Undiagnosed Multiple Myeloma Patient Identified Incidentally by Cone Beam Computed Tomography. | Am J Case Rep | 2022 | 35972908 | PubTator, text mining | PubMed |
| Emerging Roles of the Nervous System in Gastrointestinal Cancer Development. | Cancers (Basel) | 2022 | 35954387 | PubTator, text mining | PubMed |
| Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions. | Cells | 2022 | 35954171 | PubTator, text mining | PubMed |
| A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. | Sci Rep | 2022 | 35953696 | PubTator, text mining | PubMed |
| Study on the mechanism of Qiju Dihuang pill in the treatment of ophthalmic diseases based on systems pharmacology. | Medicine (Baltimore) | 2022 | 35945711 | PubTator, text mining | PubMed |
| Sarcoidosis with multiple organ involvement and uncommon symptoms: A case report. | Clin Case Rep | 2022 | 35937005 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review. | Front Pharmacol | 2022 | 35935837 | PubTator, text mining | PubMed |
| ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma. | Front Oncol | 2022 | 35912257 | PubTator, text mining | PubMed |
| Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer. | J Oncol | 2022 | 35909899 | PubTator, text mining | PubMed |
| Effect of caffeine on resting-state alpha activity across the human menstrual cycle. | Psychopharmacology (Berl) | 2022 | 35904580 | PubTator, text mining | PubMed |
| The prognostic value of autophagy related genes with potential protective function in Ewing sarcoma. | BMC Bioinformatics | 2022 | 35902797 | PubTator, text mining | PubMed |
| [Current Progress and Future Developments of Antibody Drug Conjugates in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 35899443 | PubTator, text mining | PubMed |
| Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey. | Microorganisms | 2022 | 35889004 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma. | Front Cell Dev Biol | 2022 | 35865633 | PubTator, text mining | PubMed |
| The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes. | Curr Opin Neurol | 2022 | 35856917 | PubTator, text mining | PubMed |
| Carbon dots enhance extracellular matrix secretion for dentin-pulp complex regeneration through PI3K/Akt/mTOR pathway-mediated activation of autophagy. | Mater Today Bio | 2022 | 35833197 | PubTator, text mining | PubMed |
| Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information. | NPJ Digit Med | 2022 | 35817846 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/146/papers?page=11